Sign in
CompletedNo phase

Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance With Clareon® Vivity® IOL Implantation

Key facts

Who runs it
East Coast Institute for Research
Where
Jacksonville, United StatesSee the site
Trial code
Status
Completed
People taking part
101 people enrolled
Started
10 Jul 2023
Ended
23 Jul 2024
Type of study
Observational
Record updated
10 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (11)Hide the full registry criteria

Who can take part

  • Age ≥ 18 years
  • History of adult cataract and uneventful, refractive cataract surgery with Clareon® Vivity® or Vivity® Toric intraocular lens (IOL) implantation with manifest refraction spherical equivalent (MRSE) within ±1.00 D
  • Willing to undergo an eye exam with pupil dilation

Who cannot take part

  • Yttrium aluminum garnet (YAG) laser capsulotomy within 1 month prior to enrollment
  • Laser-assisted in situ keratomileusis (LASIK) or photorefractive keratectomy (PRK) within the one year prior to IOL implantation or any time after IOL implantation
  • Any previous ocular surgery (excluding YAG, LASIK, PRK)
  • Any additional procedure(s) at the same time as the Vivity implantation including but not limited to microinvasive glaucoma surgery (MIGS)
  • Clinically significant ocular pathology; severe diabetic retinopathy, age-related macular degeneration (AMD), glaucoma, severe dry eye, irregular astigmatism, zonular weakness, pseudoexfoliation, ocular trauma
  • Moderate to severe posterior capsule opacification (2+ or more)
  • Women who are pregnant at the time of screening (based on self-reported history)
  • Medical or other problems which in the opinion of the investigator will render study participation unsafe

Where in United States

  • East Coast Institute for ResearchJacksonville, United States

About the trial

What the trial wants to find out

The goal of this observational study is to assess the effect of intraocular lens (IOL) movement in patients who have undergone Clareon® Vivity® IOL implantation.

Read full original descriptionShow less

The main question it aims to answer is: Does an association exist between IOL movement and patient quality of vision?

Participants implanted with Clareon® Vivity® and Vivity® Toric IOLs will be asked to do the following:

* consent to participate in the study * allow researchers to access their personal medical records * undergo a series of tests to assess the position of their IOLs and quality of vision

Researchers will assess participant examination results to determine whether an association exists between IOL movement and patient quality of vision.

The group in the trial

  • Individuals implanted with Clareon® Vivity® or Vivity® Toric Intraocular Lenses (IOLs)

    Individuals who have a history of adult cataract and uneventful, refractive cataract surgery with Clareon® Vivity® or Vivity® Toric IOL implantation with MRSE within ±1.00 D.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Non-Interventional Study to Evaluate the Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance in Patients Who Have Undergone Clareon® Vivity® IOL Implantation
Record updated
10 July 2026